Targeting heterogeneity of adrenocortical carcinoma: Evaluation and extension of preclinical tumor models to improve clinical translation.

While SF-1 expression in MUC-1 (100 ± 0.0%) and NCI-H295R (78.3± 12.3%) was comparable (p=n.s.), we detected a highly significant SF-1 overexpression in the pediatric ACC tumor model SJ-ACC3 (348.2± 27.4%, p < 0.001 vs.

also in 132,142 other papers